Omnicell (OMCL)
Automates medication dispensing, pharmacy compounding, and outpatient medication workflows.
$32.74
vs last close−0.43 (−1.30%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 299 | 259 | 246 | 277 | 282 | 307 | 270 | 291 | 311 | 314 | 310 | 312 |
| Cost of revenue | 167 | 153 | 151 | 162 | 160 | 164 | 159 | 163 | 176 | 184 | 170 | 159 |
| Gross profit | 132 | 105 | 95 | 114 | 123 | 143 | 111 | 128 | 135 | 130 | 140 | 153 |
| 128 | 129 | 114 | 111 | 116 | 129 | 123 | 120 | 126 | 129 | 124 | 120 | |
| Research & development | 24 | 27 | 22 | 21 | 21 | 26 | 21 | 22 | 24 | 23 | 22 | 20 |
| 104 | 102 | 92 | 90 | 94 | 103 | 102 | 98 | 102 | 106 | 102 | 100 | |
| Selling & marketing | 0 | −2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 4 | −23 | −19 | 3 | 7 | 14 | −12 | 8 | 8 | 1 | 17 | 32 |
| 4 | 5 | 1 | 5 | 4 | 10 | 2 | 2 | 1 | −1 | 0 | 1 | |
| Interest income | 4 | 5 | 0 | 0 | 0 | 0 | 4 | 4 | 3 | 1 | 2 | 0 |
| Interest expense | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 3 | 1 | 0 |
| Other non-operating income | 0 | −5 | −2 | −6 | −6 | −11 | −2 | −3 | −2 | −2 | 0 | 0 |
| Income before tax | 7 | −19 | −18 | 8 | 12 | 24 | −10 | 10 | 10 | 1 | 17 | 34 |
| Income tax expense | 2 | −4 | −2 | 4 | 3 | 8 | −3 | 5 | 4 | 3 | 6 | 10 |
| Net income from continuing operations | 6 | −14 | −16 | 4 | 9 | 16 | −7 | 6 | 5 | −2 | 11 | 24 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 6 | −14 | −16 | 4 | 9 | 16 | −7 | 6 | 5 | −2 | 11 | 24 |
| EPS, basic | $0.12 | −$0.32 | −$0.34 | $0.08 | $0.19 | $0.34 | −$0.15 | $0.12 | $0.12 | −$0.05 | $0.25 | $0.53 |
| EPS, diluted | $0.12 | −$0.32 | −$0.34 | $0.08 | $0.19 | $0.34 | −$0.15 | $0.12 | $0.12 | −$0.05 | $0.25 | $0.52 |
| Weighted average shares, basic | 45 | 45 | 46 | 46 | 46 | 46 | 47 | 47 | 46 | 45 | 45 | 45 |
| Weighted average shares, diluted | 46 | 45 | 46 | 46 | 46 | 46 | 47 | 47 | 46 | 45 | 46 | 46 |
| EBITDA | 27 | 5 | 6 | 32 | 34 | 47 | 13 | 32 | 31 | 25 | 35 | 14 |
| Depreciation & amortization | 24 | 24 | 23 | 23 | 22 | 22 | 22 | 22 | 21 | 22 | 19 | −19 |
| EBIT | 4 | −19 | −17 | 9 | 13 | 25 | −9 | 11 | 10 | 4 | 17 | 32 |